got to keep real about India - addressable market is about size of 1 wealthy european country, its all about affordability, i've seen a few indian ceos of healthcare companies present at investors meeting and take a measured view on expectations their home market. known a few smart business folks fallen in this market, maybe admedus can pull it off however as investor rather that they get their core markets up and running first.
Ann: Regulatory approval to launch CardioCel in India, page-52
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$9.78 |
Change
0.780(8.67%) |
Mkt cap ! $206.7M | |||
| Open | High | Low | Value | Volume |
| $9.00 | $9.83 | $8.68 | $324.0K | 35.80K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 970 | $9.50 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $9.85 | 1000 | 1 |
View Market Depth
| Last trade - 16.10pm 18/11/2024 (20 minute delay) ? |
| AVR (ASX) Chart |